Carl N Kraus

Summary

Publications

  1. ncbi request reprint Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education
    Carl N Kraus
    Nanotherapeutics Inc, Alachua, FL 32615, USA
    Curr Drug Saf 8:11-6. 2013
  2. ncbi request reprint The practicing clinician and regulatory safety concerns
    R G McAllister
    DrugCite Inc, USA
    Curr Drug Saf 8:17-24. 2013
  3. doi request reprint The safety record of fusidic acid in non-US markets: a focus on skin infections
    Carl N Kraus
    Infectious Diseases, Nanotherapeutics, Inc, Alachua, Florida 32615, USA
    Clin Infect Dis 52:S527-37. 2011

Collaborators

  • R G McAllister
  • TIMOTHY FRANSON

Detail Information

Publications3

  1. ncbi request reprint Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education
    Carl N Kraus
    Nanotherapeutics Inc, Alachua, FL 32615, USA
    Curr Drug Saf 8:11-6. 2013
    ..These results demonstrate that improvement in understanding of specific drug toxicities is enhanced by a CME intervention...
  2. ncbi request reprint The practicing clinician and regulatory safety concerns
    R G McAllister
    DrugCite Inc, USA
    Curr Drug Saf 8:17-24. 2013
    ..Current efforts to assess the effectiveness of regulatory efforts at risk communications should lead to changes in the approaches used and, ultimately, improvement in the safe use of both new and established drugs...
  3. doi request reprint The safety record of fusidic acid in non-US markets: a focus on skin infections
    Carl N Kraus
    Infectious Diseases, Nanotherapeutics, Inc, Alachua, Florida 32615, USA
    Clin Infect Dis 52:S527-37. 2011
    ....